Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 4/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19019798 | 0.98 | CYP4F2 (0.40) | CYP4F2CYP4A11TDP1ALDH1A1TSHR | |
| SCHEMBL19019776 | 0.96 | CYP4F2 (0.42) | CYP4F2CYP4A11TDP1ALDH1A1TSHR | |
| SCHEMBL7706303 | 0.90 | ALDH1A1 (0.41) | TDP1ALDH1A1TSHRTHRBGAA | |
| SCHEMBL7701340 | 0.90 | ALDH1A1 (0.41) | ALDH1A1TSHRTHRBGAA | |
| SCHEMBL7709308 | 0.88 | TSHR (0.41) | CYP4F2CYP4A11TDP1ALDH1A1TSHR | |
| SCHEMBL7701376 | 0.88 | TSHR (0.41) | CYP4F2CYP4A11TDP1ALDH1A1TSHR | |
| SCHEMBL6924019 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TSHRTHRBGAA | |
| SCHEMBL7706289 | 0.88 | TSHR (0.41) | CYP4F2CYP4A11TDP1ALDH1A1TSHR | |
| SCHEMBL1067047 | 0.86 | ALDH1A1 (0.44) | TDP1ALDH1A1TSHRTHRBGAA | |
| SCHEMBL703086 | 0.85 | TSHR (0.47) | ALDH1A1TSHRTHRBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10426712-B2 | Dental polymerizable composition | KURARAY NORITAKE DENTAL INC. (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20170290746-A1 | DENTAL POLYMERIZABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2017-10-12 | — | — | US | disclosed |
| US-20170240739-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITIONS | KURARAY CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3195846-A1 | DENTAL POLYMERIZABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-3184563-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | Kuraray Co., Ltd. (JP) | 2017-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426712-B2 | Dental polymerizable composition | MMAB, GRIN2B, CAD | CYP4F2 4227/4885CYP4A11 4597/4885TDP1 2116/4885 |
| US-20170290746-A1 | DENTAL POLYMERIZABLE COMPOSITION | MMAB, GRIN2B, CAD | CYP4F2 4227/4885CYP4A11 4597/4885TDP1 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.